期刊文献+

LATS2在子宫颈鳞癌组织中表达降低及其意义 被引量:1

Reduced expression of LATS2 in cervical squamous cell cancer and its clinical significance
下载PDF
导出
摘要 目的探讨子宫颈鳞癌组织中LATS2的表达情况及临床意义。方法采用免疫组化SP法检测20例正常宫颈组织和40例子宫颈鳞癌组织中LATS2的表达情况,分析其表达情况与宫颈鳞癌之间的关系。结果 LATS2在宫颈鳞癌中的细胞核表达明显低于正常宫颈上皮(P<0.05);LATS2的表达降低与患者的肿瘤大小及有无淋巴结转移明显相关(P<0.05)。结论 LATS2在宫颈鳞癌中表达降低,其异常表达可能参与了宫颈鳞癌的发生发展。 Objective To explore expression of LATS2 in cervical squamous cell cancer and its clinical signifi- cance. Methods The expression of LATS2 in 20 cases of normal cervical tissues and 40 cases of cervical squa- mous cell cancer by immunohistochemical SP were detected, and the relationship between LATS2 expression and cervical squamous cell cancer was analyzed. Results Nucleus expression of LATS2 was markedly decreased in cancer tissues compared to normal tissues (P 〈 0.05 ). Decrease of LATS2 was significantly correlated with cancer patients' tumor size and lymph node metastasis (P 〈 0. 05 ). Conclusion Expression of LATS2 is markedly de- creased in cervical squamous cell cancer and the abnormal expression of LATS2 is likely to participate in the development and progress of cervical squamous cell cancer.
出处 《安徽医科大学学报》 CAS 北大核心 2013年第12期1473-1476,共4页 Acta Universitatis Medicinalis Anhui
基金 国家自然科学基金(编号:81001168 30901606 81272881) 安徽省自然科学基金(编号:1308085MH122 11040606M176) 安徽省高校省级自然科学研究项目(编号:KJ2012Z159)
关键词 宫颈鳞癌 LATS2 肿瘤 免疫组化 宫颈 cervical squamous cell carcinoma LATS2 cancer immunohistochemistry cervical
  • 相关文献

参考文献14

  • 1Yabuta N,Fujii T,Copeland N G,et al.Structure,expression,and chromosome mapping of LATS2,a mammalian homologue ofthe Drosophila tumor suppressor gene lats/ warts [J].Genomics,2000,63(2):263-70.
  • 2Murakami H,Mizuno T,Taniguchi T,et al.LATS2 is a tumorsuppressor gene of malignant mesothelioma[J].Cancer Res,2011,71(3):873-83.
  • 3Strazisar M,Mlakar V,Glavac D.LATS2 tumour specific muta-tions and down-regulation of the gene in non-small cell carcinoma[J].Lung Cancer,2009,64(3):257-62.
  • 4Yang X,Yu J,Yin J,et al.MiR-195 regulates cell apoptosis ofhuman hepatocellular carcinoma cells by targeting LATS2 [J].Pharmazie,2012,67(7):645-51.
  • 5Lee K H,Goan Y G,Hsiao M,et al.MicroRNA-373 ( miR-373)post-transcriptionally regulates large tumor suppressor,homolog 2(LATS2) and stimulates proliferation in human esophageal cancer[J].Exp Cell Res,2009,315(15):2529-38.
  • 6Li W,Wang L,Katoh H,et al.Identification of a tumor suppres-sor relay between the F0XP3 and the Hippo pathways in breast andprostate cancer [J].Cancer Res,2011,71(6):2162-71.
  • 7Takahashi Y,Miyoshi Y,Takahata C,et al.Down-regulation ofLATS1 and LATS2 mRNAexpression by promoter hypermethylationand its association with biologically aggressive phenotype in humanbreast cancrs[J].Clin Cancer Res,2005,11(4):1380-5.
  • 8Zhang Y,Hu C F,Chen J,et al.LATS2 is demethylated andoverexpressed in nasopharyngeal carcinoma and predicts poor prog-nosis [J].BMC Cancer,2010,10:538.
  • 9Li Y,Pei J,Xia H,et al.Lats2,a putative tumor suppressor,in-hibits G1/S transition [J].Oncogene,2003,22 ( 28 ):4398-405.
  • 10Yabuta N,Mukai S,Okada N,et al.The tumor suppressor Lats2is pivotal in Aurora A and Aurora B signaling during mitosis [J].Cell Cycle,2011,10(16):2724-36.

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部